Eli Lilly: Argus Research raises target price to $1,550
LLY•Argus Research raised its target price for Eli Lilly to $1,550.
Related News
Coherent Corp.: B. Riley cuts target price to $262 from $297
COHR•
Oppenheimer raises Ligand Pharmaceuticals target price to $346 from $334
LGND•
Regeneron presents expanded Sanofi alliance worth up to $8 billion in potential payments
SNY•
Imperial announces third-quarter 2026 financial and operating results
IMO•
Carlisle Companies target price raised to $430 from $425
CSL•